Morning All!It's been a bit quiet this week so I thought I'd...

Morning All!

It's been a bit quiet this week so I thought I'd kick off the daily.

The only biotech market sensitive ann today thus far:

BDM - Griffith Uni study enhances BioDiem's antimicrobial program


In other news, AHZ's SP continues to yoyo between 5.1 and 5.5 as one of the top holders sells down at least part of their 70 million share holding - while waiting for word on Cardiocels approval.

NEU appears to be finding support around the 7.5c level - with holders hoping for the next leg up soon (which seems possible with the present momentum even without news).

POH is still languishing below value at 10c - which is surely a steal based on their pipeline and cash on hand. One of the more savvy POH investors on this board might be able to provide insight as to why.

PNO is at rock bottom with no bids whatsoever at 001 - they just can't seem to get any traction with their promising Thermalife arthritis / anti inflammatory product.

ADO after a good update to market on the 9th can't seem to find any SP momentum, with the SP refusing to stabilize over 6c in the past month.

....and that concludes my verbal diarrhea for this morning.